Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Trampert

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Hepatology|December 12, 2025
Viral infection as a trigger for primary sclerosing cholangitis in genetically susceptible individualsDavid C Trampert
Journal of Hepatology|April 10, 2026
FXR agonism in PSC recalibrated: How PRIMIS shapes endpoints and expectations for the next generation of trialsDavid C Trampert
Journal of Hepatology|May 28, 2026
On the use of UDCA beyond cholestatic liver disease: How bile acid-driven intestinal GLP-1 signalling keeps the joints healthyDavid C Trampert
Journal of Hepatology|December 12, 2024
Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBDDavid C Trampert
Journal of Hepatology|August 21, 2025
From parts to portal: Recapitulating hepatobiliary microarchitecture using multicellular organoidsDavid C Trampert
Journal of Hepatology|February 28, 2025
B cell-depleting anti-CD19 monoclonal antibody holds promise for treating IgG4-related cholangitisDavid C Trampert
Journal of Hepatology|June 6, 2025
Bile acid species as hepatic T lymphocyte response modulators - when bile acids interfere with tumor growthDavid C Trampert
Seminars in Liver Disease|May 9, 2025
IgG4-Related CholangitisUlrich Beuers, David C Trampert
Nederlands Tijdschrift Voor Geneeskunde|October 27, 2022
[Ursodeoxycholic acid: history and clinical implications]Ulrich Beuers, David C Trampert
Journal of Hepatology|January 5, 2024
A beneficial response of fetal wound healing gone bad in the bile duct: The overarching cause of biliary atresia?David C Trampert, Ulrich Beuers
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Hepatology|December 12, 2025
Viral infection as a trigger for primary sclerosing cholangitis in genetically susceptible individualsDavid C Trampert
Journal of Hepatology|April 10, 2026
FXR agonism in PSC recalibrated: How PRIMIS shapes endpoints and expectations for the next generation of trialsDavid C Trampert
Journal of Hepatology|May 28, 2026
On the use of UDCA beyond cholestatic liver disease: How bile acid-driven intestinal GLP-1 signalling keeps the joints healthyDavid C Trampert
Journal of Hepatology|December 12, 2024
Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBDDavid C Trampert
Journal of Hepatology|August 21, 2025
From parts to portal: Recapitulating hepatobiliary microarchitecture using multicellular organoidsDavid C Trampert
Journal of Hepatology|February 28, 2025
B cell-depleting anti-CD19 monoclonal antibody holds promise for treating IgG4-related cholangitisDavid C Trampert
Journal of Hepatology|June 6, 2025
Bile acid species as hepatic T lymphocyte response modulators - when bile acids interfere with tumor growthDavid C Trampert
Seminars in Liver Disease|May 9, 2025
IgG4-Related CholangitisUlrich Beuers, David C Trampert
Nederlands Tijdschrift Voor Geneeskunde|October 27, 2022
[Ursodeoxycholic acid: history and clinical implications]Ulrich Beuers, David C Trampert
Journal of Hepatology|January 5, 2024
A beneficial response of fetal wound healing gone bad in the bile duct: The overarching cause of biliary atresia?David C Trampert, Ulrich Beuers
Pageof 2